Insider Selling: pSivida Corp CEO Sells 7,000 Shares of Stock (PSDV)
pSivida Corp (NASDAQ:PSDV) CEO Paul Ashton unloaded 7,000 shares of the company’s stock on the open market in a transaction dated Thursday, June 19th. The stock was sold at an average price of $4.00, for a total transaction of $28,000.00. Following the completion of the transaction, the chief executive officer now directly owns 440,741 shares in the company, valued at approximately $1,762,964. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of pSivida Corp (NASDAQ:PSDV) traded up 0.13% on Monday, hitting $3.995. The stock had a trading volume of 63,682 shares. pSivida Corp has a 1-year low of $2.28 and a 1-year high of $5.60. The stock’s 50-day moving average is $3.76 and its 200-day moving average is $3.95. The company’s market cap is $116.9 million.
pSivida Corp (NASDAQ:PSDV) last released its earnings data on Tuesday, May 13th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.15) by $0.12. The company had revenue of $2.00 million for the quarter, compared to the consensus estimate of $0.55 million. Analysts expect that pSivida Corp will post $-0.69 EPS for the current fiscal year.
Separately, analysts at MLV & Co
initiated coverage on shares of pSivida Corp in a research note on Monday, May 5th. They set a “buy” rating and a $6.00 price target on the stock. One research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $5.43.
pSivida Corp. develops drug delivery products that are administered by implantation, injection or insertion.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.